Showing results (71-80 of 90) with videos related to
Sort By:
Pageof 9
Nature Genetics|May 1, 1996
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancerS Neuhausen, T Gilewski, L Norton, et al.Biomarker Research|February 15, 2017
A case report of concurrent embryonal rhabdomyosarcoma and diffuse large B-cell lymphoma in an adult without identifiable cancer predispositionM D Mathias, M V Ortiz, H Magnan, et al.Familial Cancer|May 26, 2006
Accuracy of BRCA1 and BRCA2 founder mutation analysis in formalin-fixed and paraffin-embedded (FFPE) tissueM A Adank, E Brogi, F Bogomolniy, et al.Nature Genetics|October 1, 1996
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%C Oddoux, J P Struewing, C M Clayton, et al.Cancer Research|July 14, 1998
Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tractB Pasche, Y Luo, P H Rao, et al.Cancer Research|December 3, 1999
TbetaR-I(6A) is a candidate tumor susceptibility alleleB Pasche, P Kolachana, K Nafa, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2013
Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the hostD J Gallagher, J Vijai, R J Hamilton, et al.Nature Genetics|September 1, 1997
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APCS J Laken, G M Petersen, S B Gruber, et al.Nature Genetics|June 1, 1996
Low incidence of BRCA2 mutations in breast carcinoma and other cancersD H Teng, R Bogden, J Mitchell, et al.British Journal of Cancer|June 13, 2015
An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortalityJ Sullivan, R Kopp, K Stratton, et al.Pageof 9